Calcium-dependent epileptogenesis in an in vitro model of stroke-induced "epilepsy"

Epilepsia

Volumn 43, Issue 11, 2002, Pages 1296-1305

  Sun, David A ^a   Sombati, Sompong ^b   Blair, Robert E ^b   Delorenzo, Robert J ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Epileptogenesis; Glutamate NMDA receptor; Stroke

Indexed keywords

BARIUM; CALCIUM; FURA 2; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; EXTRACELLULAR CALCIUM; IN VITRO STUDY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

ANIMALS; CALCIUM; CELLS, CULTURED; CEREBROVASCULAR ACCIDENT; DIZOCILPINE MALEATE; EPILEPSY; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HIPPOCAMPUS; INTRACELLULAR MEMBRANES; NEURONS; OSMOLAR CONCENTRATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 0036852605     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2002.09702.x     Document Type: Article

References (46)

1. Delgado-Escueta AV. Symptomatic lesional epilepsies: introduction. In: Delgado-Escueta AV, Wilson WA, Olsen RW, et al., eds. Jasper's basic mechanisms of the epilepsies, Philadelphia: Lippincott Williams & Wilkins, 1999:433-6.
2. Hauser WA, Hesdorffer DC. Epilepsy: frequency, causes and consequences. New York: Demos, 1990.
3. DeLorenzo RJ. The challenging genetics of epilepsy. Epilepsy Res Suppl 1991;4:3-17.
4. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991;32:429-45.
5. Sun DA, Sombati S, DeLorenzo RJ. Glutamate injury-induced epileptogenesis in hippocampal neurons: An in vitro model of stroke-induced "epilepsy." Stroke 2001;32:2344-350.
6. Witte OW, Bidmon HJ, Schiene K, et al. Functional differentiation of multiple perilesional zones after focal cerebral ischemia. J Cereb Blood Flow Metab 2000;20:1149-65.
7. Perlin JB, DeLorenzo RJ. Calcium and epilepsy. In: Pedley TA, Meldrum BS, eds. Recent advances in epilepsy. Edinburgh: Churchill Livingstone, 1992:15-36.
8. DeLorenzo RJ, Pal S, Sombati S. Prolonged activation of the N-methyl-D-aspartate receptor-Ca2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc Natl Acad Sci U S A 1998;95:14482-7.
9. Choi DW. Glutamate receptors and the induction of excitotoxic neuronal death. Prog Brain Res 1994;100:47-51.
10. Dingledine R, McBain CJ, McNamara JO. Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci 1990;11:334-8.
11. Rice AC, DeLorenzo RJ. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res 1998;782:240-7.
12. Croucher MJ, Bradford HF. NMDA receptor blockade inhibits glutamate-induced kindling of the rat amygdala. Brain Res 1990;506:349-52.
13. Croucher MJ, Bradford HF, Sunter DC, et al. Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists. Eur J Pharmacol 1988;152:29-38.
14. Stasheff SF, Anderson WW, Clark S, et al. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model. Science 1989;245:648-51.
15. Banker GA, Cowan WM. Rat hippocampal neurons in dispersed cell culture. Brain Res 1977;126:397-42.
16. Hamill OP, Marty A, Neher E, et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
17. Matsumoto H, Amjone-Marsan C. Cortical cellular phenomena in experimental epilepsy: Interictal manifestations. Exp Neurol 1964;9:286-304.
18. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
19. Pal S, Sun D, Limbrick D, et al. Epileptogenesis induces long-term alterations in intracellular calcium release and sequestration mechanisms in the hippocampal neuronal culture model of epilepsy. Cell Calcium 2001;30:285-96.
20. Limbrick DD Jr, Churn SB, Sombati S, et al. Inability to restore resting intracellular calcium levels as an early indicator of delayed neuronal cell death. Brain Res 1995;690:145-56.
21. Carafoli E. Intracellular calcium homeostasis. Annu Rev Biochem 1987;56:395-433.
22. Berridge MJ. Neuronal calcium signaling. Neuron 1998;21:13-26.
23. Nelson MT, French RJ, Krueger BK. Voltage-dependent calcium channels from brain incorporated into planar lipid bilayers. Nature 1984;308:77-80.
24. Mayer ML, Westbrook GL. Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J Physiol 1987;394:501-27.
25. Olwin BB, Storm DR. Calcium binding to complexes of calmodulin and calmodulin binding proteins. Biochemistry 1985;24:8081-6.
26. Chao SH, Suzuki Y, Zysk JR, et al. Activation of calmodulin by various metal cations as a function of ionic radius. Mol Pharmacol 1984;26:75-82.
27. Davies J, Watkins JC. Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord. Brain Res 1982;235:378-86.
28. Wong EH, Kemp JA, Priestley T, et al. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A 1986;83:7104-8.
29. Dingledine R, Borges K, Bowie D, et al. The glutamate receptor ion channels. Pharmacol Rev 1999;51:7-61.
30. Honore T, Davies SN, Drejer J, et al. Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science 1988;241:701-3.
31. Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997;37:205-37.
32. Watkins J, Collingridge G. Phenylglycine derivatives as antagonists of metabotropic glutamate receptors. Trends Pharmacol Sci 1994;15:333-42.
33. Bootman MD, Lipp P, Berridge MJ. The organisation and functions of local Ca(2+) signals. J Cell Sci 2001;114:2213-22.
34. West AE, Chen WG, Dalva MB, et al. Calcium regulation of neuronal gene expression. Proc Natl Acad Sci U S A 2001;98:11024-31.
35. Perlin JB, Churn SB, Lothman EW, et al. Loss of type II calcium/calmodulin-dependent kinase activity correlates with stages of development of electrographic seizures in status epilepticus in rat. Epilepsy Res 1992;11:111-8.
36. Bronstein JM, Micevych P, Popper P, et al. Long-lasting decreases of type II calmodulin kinase expression in kindled rat brains. Brain Res 1992;584:257-60.
37. Bronstein JM, Farber DB, Micevych PE, et al. Kindling induced changes in calmodulin kinase II immunoreactivity. Brain Res 1990;524:49-53.
38. Wasterlain CG, Bronstein JM, Morin AM, et al. Translocation and autophosphorylation of brain calmodulin kinase II in status epilepticus. Epilepsy Res Suppl 1992;9:231-8.
39. Blair RE, Churn SB, Sombati S, et al. Long-lasting decrease in neuronal Ca2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal culture model of spontaneous recurrent seizures. Brain Res 1999;851:54-65.
40. DeLorenzo RJ, Morris TA. Long-term modulation of gene expression in epilepsy. Neuroscientist 1999;5:86-99.
41. Bading H. Nuclear calcium-activated gene expression: Possible roles in neuronal plasticity and epileptogenesis. Epilepsy Res 1999;36:225-31.
42. Platenik J, Kuramoto N, Yoneda Y. Molecular mechanisms associated with long-term consolidation of the NMDA signals. Life Sci 2000;67:335-64.
43. Hardingham GE, Chawla S, Johnson CM, et al. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 1997;385:260-5.
44. Ghosh A, Greenberg ME. Calcium signaling in neurons: Molecular mechanisms and cellular consequences. Science 1995;268:239-47.
45. Morris TA, Jafari N, Rice AC, et al. Persistent increased DNA-binding and expression of serum response factor occur with epilepsy-associated long-term plasticity changes. J Neurosci 1999;19:8234-43.
46. Morris TA, Jafari N, DeLorenzo RJ. Chronic ΔFosB expression and increased AP-1 transcription factor binding are associated with the long-term plasticity changes in epilepsy. Mol Brain Res 2000;79:138-49.